EGFR and neoplasm: In vivo assessment techniques have several advantages over current ex vivo methods, including measuring EGFR expression over the entire tumor volume rather than just a section of the tumor, assessing the biologic availability of EGFR in vivo, evaluating effects of therapy on EGFR expression, and quantifying EGFR expression of all lesions in real time.